LEVOSIMENDAN REACH Reach Pharmaceuticals Pty Ltd

LEVOSIMENDAN REACH is proposed for the short-term treatment of a sudden or gradual worsening of symptoms in patients with a pre-existing heart condition, leading to inadequate blood circulation and organ congestion. It is to be used in situations where conventional therapy is not sufficient and in cases where medications to alter the force of heart muscle contractions (inotropes) may be used.